Allogene Therapeutics, Inc. (ALLO) Earnings
|
Expand Research on ALLO
| Next EPS Date | 10/30/26 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +17.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -3.8% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/12/26 | Q226 | -$0.13 | -$0.17 | +$0.04 | $4.64M | $2.22K | N/A |  | | Details | |
8/5/26  |
Q226 | N/A | -$0.17 | N/A | N/A | $2.22K | N/A | N/A | N/A | ||
| 5/13/26 | Q126 | -$0.18 | -$0.19 | +$0.01 | N/A | $2.5K | N/A | | | Details | |
| 5/7/26 |
Q126 | N/A | -$0.19 | N/A | N/A | $2.5K | N/A | N/A | N/A | ||
| 5/6/26 |
Q126 | N/A | -$0.19 | N/A | N/A | $2.5K | N/A | N/A | N/A | ||
| 3/12/26 | Q425 | -$0.17 | -$0.23 | +$0.06 | N/A | $2.22K | N/A | | | Details | |
| 11/6/25 | Q325 | -$0.19 | -$0.22 | +$0.03 | N/A | $2.22K | N/A | | | Details | |
| 10/30/25 |
Q325 | N/A | -$0.22 | N/A | N/A | $2.22K | N/A | N/A | N/A |
